Clinical trials referenced in this document:
Documents that mention this clinical trial
Interactions of ST-elevation myocardial infarction, age, and sex and the risk of major adverse cardiovascular events among Chinese adults: a secondary analysis of a single-centre prospective cohort
Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project
Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
Received: 16 January 2023
Accepted: 20 January 2023
First Online: 2 February 2023
: The study was conducted in accordance with the Declaration of Helsinki. The CCC–ACS project was approved by the institutional review board of Beijing Anzhen Hospital. The institutional review board of Beijing Anzhen Hospital waived the need for informed consent as retrospective nature of the study.
: Not applicable.
: The authors declare no competing interests.